Gillson Testing, a Keystone Capital portfolio company, has acquired Azzur Labs, a specialized analytical testing laboratory focused on microbiology and chemistry, to enhance its service offerings in the industry.
Target Information
Azzur Labs is a prominent contract analytical testing laboratory specializing in microbiology and chemistry testing, as well as inspection, certification, and compliance (TICC) services. With a strong focus on quality and precision, Azzur Labs has established itself as a critical resource for clients seeking reliable analytical services in various sectors including pharmaceuticals, food safety, and environmental analysis.
Founded with a commitment to excellence, Azzur Labs leverages cutting-edge technology and a team of skilled professionals to deliver comprehensive testing solutions. The lab's robust capabilities ensure compliance with industry regulations and provide valuable insights to clients, thus enhancing their operational efficiencies and product quality.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The analytical testing market in the United States is experiencing significant growth, driven by increasing regulatory requirements and the demand for quality assurance across various indus
Similar Deals
General Atlantic → Legent Health
2025
ChristianaCare → Crozer Health outpatient locations
2025
Long-time owner of senior living communities → American House Bluewater Bay
2025
Prime Healthcare → Ascension facilities
2025
Gallant Capital Partners, LLC → Aero Turbine, Inc.
2025
Bain Capital → HealthEdge and UST HealthProof
2025
Gillson Testing
invested in
Azzur Labs
in 2025
in a Other Private Equity deal